These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 18431145)
1. Detection of medullary thyroid cancer with MIBG imaging for pheochromocytoma. Newton TD; Augustine T; Arumugam P; Malik RA Clin Nucl Med; 2008 May; 33(5):328-9. PubMed ID: 18431145 [TBL] [Abstract][Full Text] [Related]
2. [Incidental diagnosis of medullary thyroid carcinoma (MTC) after performing 123I-metaiodobenzylguanidine (123I-MIBG) gammagraphy]. Gómez Fernández I; Zugasti Murillo A; Duran Barquero C; Ramos Moreno E; Alonso Farto JC; Almoguera Arias MI; Bittini Copano A; Domínguez Montero P; Pérez Vázquez JM Rev Esp Med Nucl; 2004; 23(5):354-6. PubMed ID: 15450143 [TBL] [Abstract][Full Text] [Related]
3. Detection of metastatic medullary thyroid cancer with 131I-MIBG scans in Sipple's syndrome. Itoh H; Sugie K; Toyooka S; Kawase M; Mukaino S; Hazama F; Endo K; Torizuka K; Nakao K; Imura H Eur J Nucl Med; 1986; 11(12):502-4. PubMed ID: 2874028 [TBL] [Abstract][Full Text] [Related]
4. Pheochromocytoma in multiple endocrine neoplasia type 2A: positive 123I MIBG with negative CT and equivocal 131I MIBG imaging. Ishii S; Shishido F; Miyajima M; Sakuma K; Kikuchi K Clin Nucl Med; 2012 Jun; 37(6):596-8. PubMed ID: 22614196 [TBL] [Abstract][Full Text] [Related]
5. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome. Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305 [TBL] [Abstract][Full Text] [Related]
9. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials]. Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549 [TBL] [Abstract][Full Text] [Related]
14. Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis. Van Der Horst-Schrivers AN; Jager PL; Boezen HM; Schouten JP; Kema IP; Links TP Anticancer Res; 2006; 26(2B):1599-604. PubMed ID: 16619578 [TBL] [Abstract][Full Text] [Related]
15. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers. Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276 [TBL] [Abstract][Full Text] [Related]
16. 123I-metaiodobenzylguanidine scans in phaeochromocytoma diagnosis: current clinical practice and relationship to biochemical screening. Tormey WP; Keeling F; Lee MJ Int J Clin Pract; 1999 Sep; 53(6):428-32. PubMed ID: 10622069 [TBL] [Abstract][Full Text] [Related]
17. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063 [TBL] [Abstract][Full Text] [Related]